Ilias Goranitis
@iliasgoranitis.bsky.social
Head, Economics of Genomics & Precision Medicine Unit, University of Melbourne | Health Economics Lead, Australian Genomics | Deputy Head, Melbourne Health Economics, Centre for Health Policy #HealthEconomics #Genomics
Reposted by Ilias Goranitis
Proud to share our BabyScreen+ #gNBS study is now out in @naturemedicine.bsky.social: 1000 babies screened, results in <2wks, 16 high chance findings, incl. 2 with major impact on care. Big thanks to @zornitza.bsky.social and the study team!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Feasibility, acceptability and clinical outcomes of the BabyScreen+ genomic newborn screening study - Nature Medicine
The BabyScreen+ study offered genomic screening to 1,000 newborns in Australia, and showed that the approach is feasible and positively received by families, leading to molecular diagnoses in 1.6% of babies.
www.nature.com
October 9, 2025 at 8:56 PM
Proud to share our BabyScreen+ #gNBS study is now out in @naturemedicine.bsky.social: 1000 babies screened, results in <2wks, 16 high chance findings, incl. 2 with major impact on care. Big thanks to @zornitza.bsky.social and the study team!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Ilias Goranitis
🤗 Out now @naturemedicine.bsky.social results of our genomic NBS study BabyScreen+ 👶🧬
👉 www.nature.com/articles/s41...
1,000 babies
WGS using existing cards
600+ conditions
13 day TAT
16 diagnoses (vs 1 in std NBS)
High clinical impact
High parental acceptability
👉 www.nature.com/articles/s41...
1,000 babies
WGS using existing cards
600+ conditions
13 day TAT
16 diagnoses (vs 1 in std NBS)
High clinical impact
High parental acceptability
October 9, 2025 at 8:03 PM
🤗 Out now @naturemedicine.bsky.social results of our genomic NBS study BabyScreen+ 👶🧬
👉 www.nature.com/articles/s41...
1,000 babies
WGS using existing cards
600+ conditions
13 day TAT
16 diagnoses (vs 1 in std NBS)
High clinical impact
High parental acceptability
👉 www.nature.com/articles/s41...
1,000 babies
WGS using existing cards
600+ conditions
13 day TAT
16 diagnoses (vs 1 in std NBS)
High clinical impact
High parental acceptability
Help us develop a roadmap for stakeholders to consider when integrating #healtheconomics alongside #genomics to inform decision-making. Please share your local perspectives on challenges & opportunities of evaluating and implementing genomics
q.surveys.unimelb.edu.au/jfe/form/SV_...
q.surveys.unimelb.edu.au/jfe/form/SV_...
Qualtrics Survey | Qualtrics Experience Management
The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.
q.surveys.unimelb.edu.au
July 19, 2025 at 2:58 AM
Help us develop a roadmap for stakeholders to consider when integrating #healtheconomics alongside #genomics to inform decision-making. Please share your local perspectives on challenges & opportunities of evaluating and implementing genomics
q.surveys.unimelb.edu.au/jfe/form/SV_...
q.surveys.unimelb.edu.au/jfe/form/SV_...
Wonderful to see our paper on the #Value and #Implementation of #Genomic_Newborn_Screening published in @ajhgnews.bsky.social #BabyScreen+ #HealthEconomics #DCE
📣New today!
📄Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in Australia
🧑🤝🧑 @iliasgoranitis.bsky.social @zornitza.bsky.social & co
📄Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in Australia
🧑🤝🧑 @iliasgoranitis.bsky.social @zornitza.bsky.social & co
Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in Australia
Genomics will potentially transform newborn screening programs globally. To inform
implementation, we surveyed 2,509 members of the Australian public to understand the
importance they place on key asp...
www.cell.com
May 29, 2025 at 2:54 AM
Wonderful to see our paper on the #Value and #Implementation of #Genomic_Newborn_Screening published in @ajhgnews.bsky.social #BabyScreen+ #HealthEconomics #DCE
Reposted by Ilias Goranitis
What does the Australian public think about the value and implementation of genomic NBS? 🧬👶⚖️
@ajhgnews.bsky.social
@iliasgoranitis.bsky.social @stephaniebest.bsky.social @genomeseb.bsky.social @genetic-fi.bsky.social
#raredisease #genomics #healtheconomics
www.sciencedirect.com/science/arti...
@ajhgnews.bsky.social
@iliasgoranitis.bsky.social @stephaniebest.bsky.social @genomeseb.bsky.social @genetic-fi.bsky.social
#raredisease #genomics #healtheconomics
www.sciencedirect.com/science/arti...
Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in Australia
Integrating genomic sequencing into newborn screening (NBS) has transformative potential for the identification and management of genetic conditions. …
www.sciencedirect.com
May 28, 2025 at 5:12 PM
What does the Australian public think about the value and implementation of genomic NBS? 🧬👶⚖️
@ajhgnews.bsky.social
@iliasgoranitis.bsky.social @stephaniebest.bsky.social @genomeseb.bsky.social @genetic-fi.bsky.social
#raredisease #genomics #healtheconomics
www.sciencedirect.com/science/arti...
@ajhgnews.bsky.social
@iliasgoranitis.bsky.social @stephaniebest.bsky.social @genomeseb.bsky.social @genetic-fi.bsky.social
#raredisease #genomics #healtheconomics
www.sciencedirect.com/science/arti...
Reposted by Ilias Goranitis
A few weeks ago, @iliasgoranitis.bsky.social
presented at the Pan American Health Organisation webinar series. The webinar explored the challenges and opportunities of incorporating genomic innovations into health systems. youtube.com/watch?v=cPQr...
presented at the Pan American Health Organisation webinar series. The webinar explored the challenges and opportunities of incorporating genomic innovations into health systems. youtube.com/watch?v=cPQr...
Genomics in public health: Technology assessment
YouTube video by PAHO TV
youtube.com
April 10, 2025 at 5:21 AM
A few weeks ago, @iliasgoranitis.bsky.social
presented at the Pan American Health Organisation webinar series. The webinar explored the challenges and opportunities of incorporating genomic innovations into health systems. youtube.com/watch?v=cPQr...
presented at the Pan American Health Organisation webinar series. The webinar explored the challenges and opportunities of incorporating genomic innovations into health systems. youtube.com/watch?v=cPQr...
A must-read:
The Cost-Effectiveness of #Genomic_Medicine in #Cancer Control: A Systematic Literature Review
link.springer.com/article/10.1...
Grateful to the @who.int and Cancer Australia for their support.
The Cost-Effectiveness of #Genomic_Medicine in #Cancer Control: A Systematic Literature Review
link.springer.com/article/10.1...
Grateful to the @who.int and Cancer Australia for their support.
The Cost Effectiveness of Genomic Medicine in Cancer Control: A Systematic Literature Review - Applied Health Economics and Health Policy
Background and Objective Genomic medicine offers an unprecedented opportunity to improve cancer outcomes through prevention, early detection and precision therapy. Health policy makers worldwide are d...
link.springer.com
April 3, 2025 at 9:37 PM
A must-read:
The Cost-Effectiveness of #Genomic_Medicine in #Cancer Control: A Systematic Literature Review
link.springer.com/article/10.1...
Grateful to the @who.int and Cancer Australia for their support.
The Cost-Effectiveness of #Genomic_Medicine in #Cancer Control: A Systematic Literature Review
link.springer.com/article/10.1...
Grateful to the @who.int and Cancer Australia for their support.
Reposted by Ilias Goranitis
As @ausgenomics.bsky.social comes to an end: what have we learned? 🇦🇺🧬 @naturemedicine.bsky.social
👉 rdcu.be/eeuAN
Change is hard! Key for success: working across disciplines; jurisdictions; and all leadership levels🏆
@stephaniebest.bsky.social @iliasgoranitis.bsky.social @andrewmallett8.bsky.social
👉 rdcu.be/eeuAN
Change is hard! Key for success: working across disciplines; jurisdictions; and all leadership levels🏆
@stephaniebest.bsky.social @iliasgoranitis.bsky.social @andrewmallett8.bsky.social
Using implementation science to navigate the complexity of integrating genomics into healthcare
Nature Medicine - Australian Genomics led a country-level, longitudinal project to deliver and evaluate the impact of genomics in routine healthcare.
rdcu.be
March 24, 2025 at 4:56 AM
As @ausgenomics.bsky.social comes to an end: what have we learned? 🇦🇺🧬 @naturemedicine.bsky.social
👉 rdcu.be/eeuAN
Change is hard! Key for success: working across disciplines; jurisdictions; and all leadership levels🏆
@stephaniebest.bsky.social @iliasgoranitis.bsky.social @andrewmallett8.bsky.social
👉 rdcu.be/eeuAN
Change is hard! Key for success: working across disciplines; jurisdictions; and all leadership levels🏆
@stephaniebest.bsky.social @iliasgoranitis.bsky.social @andrewmallett8.bsky.social
Reposted by Ilias Goranitis
(1/4) Attention Early Career Researchers (ECRs)! We are still collecting expressions of interest for our ECR ‘Preprint Club’ series for 2025. #IHEA #healtheconomics #genomics #precisionmedicine
March 18, 2025 at 9:26 AM
(1/4) Attention Early Career Researchers (ECRs)! We are still collecting expressions of interest for our ECR ‘Preprint Club’ series for 2025. #IHEA #healtheconomics #genomics #precisionmedicine
Reposted by Ilias Goranitis
What happens when #genomic testing is funded?🧬
👉 rdcu.be/d8MSL
Last 10yrs 🇦🇺:
Many tests approved as evidence grows ✅
BUT testing volumes low AND inequitable access
Budget impact of #genomics minor: AU$3Mpa or <0.01% of all health expenditure 💰
@ausgenomics.bsky.social @iliasgoranitis.bsky.social
👉 rdcu.be/d8MSL
Last 10yrs 🇦🇺:
Many tests approved as evidence grows ✅
BUT testing volumes low AND inequitable access
Budget impact of #genomics minor: AU$3Mpa or <0.01% of all health expenditure 💰
@ausgenomics.bsky.social @iliasgoranitis.bsky.social
Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014–2023
European Journal of Human Genetics - Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014–2023
rdcu.be
February 6, 2025 at 3:25 AM
What happens when #genomic testing is funded?🧬
👉 rdcu.be/d8MSL
Last 10yrs 🇦🇺:
Many tests approved as evidence grows ✅
BUT testing volumes low AND inequitable access
Budget impact of #genomics minor: AU$3Mpa or <0.01% of all health expenditure 💰
@ausgenomics.bsky.social @iliasgoranitis.bsky.social
👉 rdcu.be/d8MSL
Last 10yrs 🇦🇺:
Many tests approved as evidence grows ✅
BUT testing volumes low AND inequitable access
Budget impact of #genomics minor: AU$3Mpa or <0.01% of all health expenditure 💰
@ausgenomics.bsky.social @iliasgoranitis.bsky.social
New paper in the European Journal of Human Genetics:
Utilisation of subsidised genetic and genomic testing in Australia during 2014–2023
www.nature.com/articles/s41...
Utilisation of subsidised genetic and genomic testing in Australia during 2014–2023
www.nature.com/articles/s41...
Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014–2023 - European Journal of Human Genetics
European Journal of Human Genetics - Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014–2023
www.nature.com
February 6, 2025 at 12:05 AM
New paper in the European Journal of Human Genetics:
Utilisation of subsidised genetic and genomic testing in Australia during 2014–2023
www.nature.com/articles/s41...
Utilisation of subsidised genetic and genomic testing in Australia during 2014–2023
www.nature.com/articles/s41...
@CancerAustralia has now launched the National Framework for Genomics in Cancer Control. www.canceraustralia.gov.au/key-initiati...
It was an honor to lead the #healtheconomics component of the evidence review that informed the development of this framework. Access it through link ⬇️
It was an honor to lead the #healtheconomics component of the evidence review that informed the development of this framework. Access it through link ⬇️
www.canceraustralia.gov.au
February 5, 2025 at 11:31 PM
@CancerAustralia has now launched the National Framework for Genomics in Cancer Control. www.canceraustralia.gov.au/key-initiati...
It was an honor to lead the #healtheconomics component of the evidence review that informed the development of this framework. Access it through link ⬇️
It was an honor to lead the #healtheconomics component of the evidence review that informed the development of this framework. Access it through link ⬇️
Reposted by Ilias Goranitis
How do we measure the value of #genomics for #policy decisions? Check out our new GUV scale!
👉 www.valueinhealthjournal.com/article/S109...
👏 great collaboration @iliasgoranitis.bsky.social @andrewmallett8.bsky.social @stephaniebest.bsky.social @zoefehlberg.bsky.social @ausgenomics.bsky.social
👉 www.valueinhealthjournal.com/article/S109...
👏 great collaboration @iliasgoranitis.bsky.social @andrewmallett8.bsky.social @stephaniebest.bsky.social @zoefehlberg.bsky.social @ausgenomics.bsky.social
A Standardized Measurement and Valuation Scale of Genomic Utility for Policy Decisions: The GUV Scale
The multifaceted ways in which genomics can be valuable to clinicians, patients, families,
and society are important for informing prioritization decisions by policy makers.
This study aims to develop...
www.valueinhealthjournal.com
January 13, 2025 at 7:37 AM
How do we measure the value of #genomics for #policy decisions? Check out our new GUV scale!
👉 www.valueinhealthjournal.com/article/S109...
👏 great collaboration @iliasgoranitis.bsky.social @andrewmallett8.bsky.social @stephaniebest.bsky.social @zoefehlberg.bsky.social @ausgenomics.bsky.social
👉 www.valueinhealthjournal.com/article/S109...
👏 great collaboration @iliasgoranitis.bsky.social @andrewmallett8.bsky.social @stephaniebest.bsky.social @zoefehlberg.bsky.social @ausgenomics.bsky.social
GUV-scale
New way to measure & score genomic utility on a 0-100% scale based on 5 policy priority indicators (clinical, diagnostic, economic, societal, and family utility)
doi.org/10.1016/j.jv...
@zornitza.bsky.social @stephaniebest.bsky.social @andrewmallett8.bsky.social @ausgenomics.bsky.social
New way to measure & score genomic utility on a 0-100% scale based on 5 policy priority indicators (clinical, diagnostic, economic, societal, and family utility)
doi.org/10.1016/j.jv...
@zornitza.bsky.social @stephaniebest.bsky.social @andrewmallett8.bsky.social @ausgenomics.bsky.social
Redirecting
doi.org
January 13, 2025 at 5:40 AM
GUV-scale
New way to measure & score genomic utility on a 0-100% scale based on 5 policy priority indicators (clinical, diagnostic, economic, societal, and family utility)
doi.org/10.1016/j.jv...
@zornitza.bsky.social @stephaniebest.bsky.social @andrewmallett8.bsky.social @ausgenomics.bsky.social
New way to measure & score genomic utility on a 0-100% scale based on 5 policy priority indicators (clinical, diagnostic, economic, societal, and family utility)
doi.org/10.1016/j.jv...
@zornitza.bsky.social @stephaniebest.bsky.social @andrewmallett8.bsky.social @ausgenomics.bsky.social
New role within our Economics of Genomics & Precision Medicine Unit - Applications deadline Jan 20 #healtheconomics
jobs.unimelb.edu.au/caw/en/job/9...
jobs.unimelb.edu.au/caw/en/job/9...
Details : Research Assistant / Research Fellow, Health Economics : The University of Melbourne
Careers at The University of Melbourne
jobs.unimelb.edu.au
December 16, 2024 at 2:17 AM
New role within our Economics of Genomics & Precision Medicine Unit - Applications deadline Jan 20 #healtheconomics
jobs.unimelb.edu.au/caw/en/job/9...
jobs.unimelb.edu.au/caw/en/job/9...
Honoured to receive a Dame Kate Campbell Fellowship and join excellent colleagues in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne who have inspired me with their work over the years!
December 2, 2024 at 5:59 AM
Honoured to receive a Dame Kate Campbell Fellowship and join excellent colleagues in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne who have inspired me with their work over the years!
An important step towards the economic evaluation of #FunctionalGenomics! A #MicroCosting of mass-spectrometry based quantitative #Proteomics url.au.m.mimecastprotect.com/s/TeIxCxnMJ5... @ausgenomics.bsky.social
A micro-costing study of mass-spectrometry based quantitative proteomics testing applied to the diagnostic pipeline of mitochondrial and other rare disorders
url.au.m.mimecastprotect.com
December 1, 2024 at 6:47 AM
An important step towards the economic evaluation of #FunctionalGenomics! A #MicroCosting of mass-spectrometry based quantitative #Proteomics url.au.m.mimecastprotect.com/s/TeIxCxnMJ5... @ausgenomics.bsky.social
Economics of Genomics and Precision Medicine Unit Strategy Day reflections and fun - So proud of the personal & professional qualities of my team #HealthEconomics #Genomics
November 29, 2024 at 11:54 AM
Economics of Genomics and Precision Medicine Unit Strategy Day reflections and fun - So proud of the personal & professional qualities of my team #HealthEconomics #Genomics
Reposted by Ilias Goranitis
On Friday the Australian Government made an important announcement about the new #GenomicsAustralia, a national body that will provide leadership, coordination and expertise so all Australians can reap the benefits of cutting-edge genomic research and technologies.
www.health.gov.au/ministers/th...
www.health.gov.au/ministers/th...
www.health.gov.au
November 18, 2024 at 5:45 AM
On Friday the Australian Government made an important announcement about the new #GenomicsAustralia, a national body that will provide leadership, coordination and expertise so all Australians can reap the benefits of cutting-edge genomic research and technologies.
www.health.gov.au/ministers/th...
www.health.gov.au/ministers/th...
Reposted by Ilias Goranitis
Meet our team! @jbuchanan-ox.bsky.social, Ilias Goranitis, and Deirdre Weymann are the founders and lead conveners of the International Health Economics Association Genomics & Precision Medicine Special Interest Group (i.e., the
#IHEA Econ-Omics SIG).
#healtheconomics #genomics #precisionmedicine
#IHEA Econ-Omics SIG).
#healtheconomics #genomics #precisionmedicine
November 20, 2024 at 8:22 AM
Meet our team! @jbuchanan-ox.bsky.social, Ilias Goranitis, and Deirdre Weymann are the founders and lead conveners of the International Health Economics Association Genomics & Precision Medicine Special Interest Group (i.e., the
#IHEA Econ-Omics SIG).
#healtheconomics #genomics #precisionmedicine
#IHEA Econ-Omics SIG).
#healtheconomics #genomics #precisionmedicine